Bond valence sums and structural studies of antimony complexes containing Sb bonded only to O ligands

New R₀ values for Sb(III)-O of 1.955(13) Å and for Sb(V)-O of 1.912(12) Å were derived from a bond valence sum, or BVS, analysis of of 123 SbO_n fragments with n = 3-7. These R₀ values can be used to calculate the oxidation state, or OS, of Sb in complexes where Sb is bonded only to O ligands. If the OS of the Sb ion is uncertain, the average R₀ value of 1.934 Å can be used to decide between the +3 or +5 OS from the observed Sb-O bond distances without any assumptions. The Sb-O distances used in deriving the R₀ values for the +3 and +5 complexes are tabulated as a function of coordination number and have a wide range of values, but the average Sb-O distance reflects the requirement that the BVS must equal the OS. To supplement the Sb-O data, 2 new antimony tartrates were synthesized, and their crystal structures were determined. A single crystal structure determination of NaSb(OH)₆, an unexpected reaction product, gave Sb-O distances that were also included in our BVS analysis.     

New complexes of La(III), Ce(III), Pr(III), Nd(III), Sm(III), Eu(III) and Gd(III) ions with morin

New solid complex compounds of La(III), Ce(III), Pr(III), Nd(III), Sm(III), Eu(III) and Gd(III) ions with morin were synthesized. The molecular formula of the complexes is Ln(C₁₅H₉O₇)₃ · nH₂O, where Ln is the cation of lanthanide and n = 6 for La(III), Sm(III), Gd(III) or n = 8 for Ce(III), Pr(III), Nd(III) and Eu(III). Thermogravimetric studies and the values of dehydration enthalpy indicate that water occurring in the compounds is not present in the inner coordination sphere of the complex. The structure of the complexes was determined on the basis of UV-visible, IR, MS, ¹H NMR and ¹³C NMR analyses. It was found that in binding the lanthanide ions the following groups of morin take part: 3OH and 4CO in the case of complexes of La, Pr, Nd, Sm and Eu, or 5OH and 4CO in the case of complexes of Ce and Gd. The complexes are five- and six-membered chelate compounds.     

Synthesis and spectroscopic characterization of organotin(IV) complexes with 2-benzoylpyridine-N(4)-cyclohexylthiosemicarbazone (HBPCT): X-ray crystal structure of [PhSnCl2(BPCT)]

The reaction of 2-benzoylpyridine-N(4)-cyclohexylthiosemicarbazone [HBPCT, (1)] ligand with organotin(IV) chloride(s) lead to the formation of three new organotin(IV) complexes: [MeSnCl₂(BPCT)] (2), [PhSnCl₂(BPCT)] (3) and [Ph₂SnCl(BPCT)] (4). The ligand (1) and its organotin(IV) complexes (2-4) have been synthesized and characterized by CHN analyses, molar conductivity, UV-Vis, FT-IR and ¹H NMR spectral studies. The single crystal X-ray diffraction studies indicated that [PhSnCl₂(BPCT)] (3) is six coordinated and adopts strongly a distorted octahedral configuration with the coordination through pyridine-N, azomethine-N and thiolato-S atoms of the ligand. The crystal system of [PhSnCl₂(BPCT)] (3) is orthorhombic with space group P2ac2n and the unit cell dimensions: a = 28.1363(5) Å, b = 9.5970(2) Å, c = 9.4353(2) Å.     

Cu(II) complexes with labile apical coordination: Synthesis, crystal structure, H NMR investigation, and oxidation properties of mononuclear [Cu(dien)(2-PhIm)(ClO4)] (1), [Cu(dien)(2-MeBzIm)] (2), complexes

The compounds [Cu(dien)(2-PhIm)(ClO₄)](ClO₄) (1); [Cu(dien)(2-MeBzIm)](ClO₄)₂ (2); where dien = diethylenetriamine, 2-PhIm = 2-phenylimidazole and 2-MeBzIm = 2-methylbenzimidazole, were synthesized and characterized. The complexes possessing [Cu(II)dien] moiety as common, the former containing 2-phenylimidazole, yielded square pyramidal geometry with apical perchlorate coordination [Cu1-O(5) = 2.449 Å], while the latter with 2-methylbenzimidazole formed square planar geometry with weak perchlorate contact [Cu1-O(8) = 2.596 Å] in its apical position. The effect of solvent and the variable temperature ¹H NMR investigation combinedly explore the geometrical rearrangement towards five coordination around Cu(II) metal center by accommodating the solvent molecule in its fifth coordination. Possessing easily labile perchlorate anion, both these complexes were investigated for their oxidation capability using 3,5-di-tert-butyl catechol (DTBC). The rate constant determined for the oxidation of DTBC to corresponding quinone indicates that they are catalytically quite similar and the k_cat of 1 ≈ 2. The crystal structure and the NMR investigations are discussed in detail.     

Octahedral hexanuclear complexes involving light lanthanide ions

Two new hexanuclear complexes involving two of the lightest lanthanide ions have been synthesized and structurally described. Their chemical formula is [Ln₆(μ₆-O)(μ₃-OH)₈(NO₃)₆(H₂O)₁₄] · 2NO₃ · 2H₂O with Ln = Pr or Nd. The structure has been solved for the Pr³⁺-containing compound. It crystallizes in the monoclinic system, space group P21/n (no. 14) with a = 12.4163(2) Å, b = 10.51210(10) Å, c = 16.0389(2) Å, β = 95.7810(6)° and Z = 4. The chemical and thermal stabilities of both the compounds have been studied. These studies reveal that they can be used as molecular chemical precursors for further materials synthesis. To the best of our knowledge, this praseodymium-containing hexanuclear complex is the first ever reported.     

Synthesis and X-ray structural characterization of tris(l-glycinato)vanadium(III) and trans-tetraquadichlorovanadium(III) chloride

Despite the importance of V^III in biology, only three V^III complexes of naturally occurring amino acids have been structurally characterized. We report the structure of the first vanadium complex incorporating a glycine ligand, [V(Gly)₃] · 2DMSO, which crystallizes in a monoclinic system with space group Cc, a = 8.9186(5) Å, b = 21.5347(9) Å, c = 9.9064(5) Å and β = 110.536(3)°. The X-ray structural data show the central V^III metal octahedrally coordinated by three bidentate glycinato ligands arranged a mer configuration, with both Δ and Λ enantiomers present in the unit cell. The bulk sample was isolated as [V(Gly)₃] · DMSO · NaCl. Structural comparisons are made with the corresponding homoleptic glycinato complexes of Co^III, Cr^III and Ni^II. The structure of trans-[V(OH₂)₄Cl₂]Cl · 2H₂O has also been re-determined. This latter complex crystallizes in a monoclinic system in the P2(1)/c space group, a = 6.4381(9) Å, b = 6.3843(9) Å, c = 11.7980(17) Å and β = 98.057(2)°. The vanadium atom lies at a crystallographic inversion centre within the distorted octahedron formed by the four water and two chloride ligands.     

One-dimensional azido-bridged chiral copper(II) coordination polymers: Syntheses, structures and magnetic studies

Two new one-dimensional azido-bridged chiral copper(II) coordination polymers, [(μ-1,1,3-N₃)₂{Cu₂(R-L)₂(N₃)₂}]_n (1) (R-L = R-2-(N-(2-hydroxybutyl)carbaldimino) pyridine) and [(μ-1,1,3-N₃)₂{Cu₂(S-L)₂(N₃)₂}]_n (2) (S-L = S-2-(N-(2-hydroxybutyl)carbaldimino)pyridine) have been synthesized and structurally characterized. Complexes 1 and 2 crystallize in the monoclinic chiral space group P2₁. For 1, with a = 6.9565(17) Å, b = 20.675(5) Å, c = 9.859(2) Å, β = 105.944(5)° and Z = 2. In the case of compound 2, a = 6.9650(17) Å, b = 20.705(5) Å, c = 9.878(2) Å, β = 105.941(4)° and Z = 2. Both complexes consist of one-dimensional chiral structures in which the copper(II) ions with a distorted octahedral geometry are interlinked by the unusual μ-1,1,3 azido ligands. Circular dichroism spectra demonstrate that 1 and 2 are a pair of enantiomers. Their magnetic properties have been studied. Fitting of the susceptibility data for 1 and 2 using the Bleany-Bowers expression derived from the isotropic spin-exchange Hamiltonian H = −2JS₁S₂ leads to the parameters g = 2.21, J = −2.06 cm⁻¹, zJ′ = −0.0309 cm⁻¹ and R = 4.0 × 10⁻⁴.     

Synthesis and characterization of tetraphenylporphyrin manganese(III) complexes of phenylcyanamide ligands

Several complexes of TPPMn-L, where TPP is the dianion of tetraphenylporphyrin and L is monoanion of 4-methylphenylcyanamide (4-Mepcyd) (1), 2,4-dimethylphenylcyanamide (2,4-Me₂pcyd) (2), 3,5-dimethylphenylcyanamide (3,5-Me₂pcyd) (3), 4-methoxyphenylcyanamide (4-MeOpcyd) (4), phenylcyanamide (pcyd) (5), 2-chlorophenylcyanamide (2-Clpcyd) (6), 2,5-dichlorophenylcyanamide (2,5-Cl₂pcyd) (7), 2,6-dichlorophenylcyanamide (2,6-Cl₂pcyd) (8), 4-bromophenylcyanamide (4-Brpcyd) (9), and 2,3,4,5-tetrachlorophenylcyanamide (2,3,4,5-Cl₄pcyd) (10), have been prepared from the reaction of TPPMnCl and thallium salt of related phenylcyanamide. Each of the complexes has been characterized by IR, UV-Vis and ¹H NMR spectroscopies.4-Methylphenylcyanamidotetraphenylporphyrin manganese(III) crystallized with one molecule of solvent CHCl₃ in the triclinic crystal system and space group with the following unit cell parameters of: a = 11.596(6) Å; b = 11.768(9) Å; c = 17.81(2) Å; and α, β, γ are 88.91(9)°, 88.16(7)°, 67.90(5)°, respectively; V = 2251(3) Å³; Z = 2. A total of 4234 reflections with I > 2σ(I) were used to refine the structure to R = 0.0680 and R_w = 0.2297. The Mn(III) shows slightly distorted square pyramidal coordination with the 4-methylphenylcyanamide in the axial position, coordinated from nitrile nitrogen. The reduction of each of the TPPMn-L complexes was also examined in dichloromethane and spectroelectrochemical behavior of (1) was investigated and compared to TPPMnCl.     

Highly symmetrical chromium(II) bisdiketiminate complexes

Reaction of the lithium salts of N,N′-dialkyl-2-amino-4-imino-pent-2-enes, nacnac^RLi(THF) (R = CH₂Ph, Cy, nPr, iBu or S-CH(Me)Ph), with half an equivalent of CrCl₂(THF)_x yielded the homoleptic complexes (nacnac^R)₂Cr. All complexes were characterized by X-ray diffraction studies and displayed a highly symmetric, square-planar coordination around the chromium center with strong boat-like distortions of the diketiminate ligands. Reaction of nacnac^RLi(THF) (R = CH₂Ph, Cy) with one equivalent of CrCl₂(THF)_x afforded the dimeric complexes {nacnac^RCr(μ-Cl)}₂.     

Platinum(IV) complexes with ethylenediamine-N,N′-diacetate diester (R2edda) ligands: Synthesis, characterization and in vitro antitumoral activity

The novel N,N-type bidentate ligand precursors, diethyl, dipropyl esters of ethylenediamine-N,N′-diacetic acid dihydrochloride (HOOCCH₂NHCH₂CH₂NHCH₂COOH · 2HCl, H₂edda · 2HCl), and the corresponding tetrachloroplatinum(IV) complexes, [PtCl₄(R₂edda)] · H₂O (ROOCCH₂NHCH₂CH₂NHCH₂COOR, R = Me, Et, n-Pr), were synthesized. The esters coordinated as bidentate ligands via both N donor atoms. The esters, as well as the complexes, have been characterized by infrared, ¹H and ¹³C NMR spectroscopy and elemental analysis. Solid state structures of both dimethyl and diethyl ester platinum(IV) complexes have been determined by X-ray crystallography. Quantum chemical calculations were performed in order to investigate diastereoselectivity in the formation of the platinum(IV) complexes. The in vitro cytotoxic evaluation of the investigated complexes in human tumor cell lines 1411HP, H12.1 (both testicular germ cell tumors), DLD-1 (colon carcinoma), 518A2 (melanoma), A549 (lung carcinoma) and liposarcoma showed a dose-dependent antiproliferative effect in all cell lines. Remarkably, the highest cytotoxic activity was observed in the cisplatin-resistant cell line 1411HP. In addition, at higher concentrations the treatment with these complexes led to the induction of apoptosis in all cell lines except for DLD-1.     

Synthesis of bimetallic fulvalene and bis(cyclopentadienyl)methane derivatives of niobium and tantalum tetracarbonyl

Ring coupled bimetallic derivatives (μ-η^5:5-C₅H₄C₅H₄)[Nb(CO)₄]₂ and [μ-CH₂(η⁵-C₅H₄)₂][M(CO)₄]₂, where M = Nb and Ta have been prepared. The molecular structures of the latter two compounds have been determined: , triclinic, , a = 8.028(2) Å, b = 11.414(1) Å, c = 12.711(2) Å, α = 75.020(8)°, β = 80.34(2)°, γ = 79.46(2)°, V = 1097.3(4) ų, Z = 2, R(F) = 2.79%; [μ-CH₂(η⁵-C₅H₄)₂][Ta(CO)₄]₂, triclinic, , a = 7.815(3) Å, b = 10.275(4) Å, c = 13.135(4) Å, α = 104.25(3)°, β = 100.26(4)°, γ = 96.86(3)°, V = 991.2(6) ų, Z = 2, R(F) = 3.00%.     

Synthesis, spectroscopic characterization and structural studies of chloro dioxotriphenylphosphine oxide (O,O-dialkyl/diphenyl(alkylene)dithiophosphate) molybdenum(VI) complexes: crystal structure of MoO2Cl2(OSMe2)2

Reactions of dichlorodioxobis(triphenylphosphine oxide)molybdenum(VI) complexes with ammonium/sodium salts of O,O-dialkyl(alkylene) and diphenyl dithiophosphoric acids in 1:1 molar ratio in dichloromethane solution yield dioxomolybdenum complexes of the types, MoO₂Cl[S₂P(OR)₂] · OPPh₃ (R=Me, Et, i-Pr, Ph) and MoO₂Cl[S₂] · OPPh₃. (G=-CH₂CMe₂CH₂O-, -OCMe₂CMe₂O-). These newly synthesized compounds were characterized by IR, UV-visible and ¹H NMR spectroscopy and elemental analysis. The molecular structure of MoO₂Cl₂(OSMe₂)₂ was determined by single-crystal X-ray diffraction. MoO₂Cl₂(OSMe₂)₂ crystallizes as orthorhombic in the space group Pbca with cell parameters a=13.7235(3) Å, b=12.2429(2) Å, c=14.3356(3) Å, V=2408.60(8) Å⁻³, Z=8, R=0.0221, R_w=0.0519. There are two cis oxo ligands, two cis dimethylsulphoxide moieties and two trans chlorine atoms in a distorted octahedral environment around molybdenum.     

Synthesis, characterization, and aqueous chemistry of cytotoxic Au(III) polypyridyl complexes

This work reports the synthesis, characterization, and aqueous chemistry of a series of cytotoxic [Au(polypyridyl)Cl₂]PF₆ complexes {(where polypyridyl = dipyrido[3,2-f:2′,3′-h] quinoxaline (DPQ), dipyrido[3,2-a:2′,3′-c] phenazine (DPPZ) and dipyrido[3,2-a:2′,3′-c](6,7,8,9-tetrahydro) phenazine (DPQC))}. The crystal structure of [Au(DPQ)Cl₂]PF₆ was determined as example of the series and exhibits the anticipated square planar geometry common for d⁸ coordination complexes. The crystals of the complex belong to the space group P2₁/n with a = 7.624(2) Å, b = 18.274(5) Å, c = 14.411(14) Å, β = 98.03(3)°, and Z = 4. In ¹H NMR studies of these compounds in the presence of aqueous buffer, all four complexes rapidly converted to the dihydroxy species [Au(polypyridyl)(OH)₂] in a stepwise fashion. However, the [Au(polypyridyl)]³⁺ fragment believed to impart cytotoxicity in human ovarian cancer cell lines (A2780) remained intact and appeared stable for days. It was also noted that these Au(III) complexes were readily reduced in the presence of the common biological reducing agents, reduced glutathione and sodium ascorbate. How solution and redox stability may affect the biological activity of these novel Au(III) complexes is discussed.     

Structure and spectroscopic studies of cis-bis(bipyridine) ruthenium(II) complexes of phenylcyanamide ligands

New ruthenium(II) complexes with cyanamide ligands, cis-[Ru(bpy)₂(Ipcyd)₂] (1) and [Ru(bpy)₂(OHpcyd)₂] (2) (bpy = 2,2′-bipyridine, Ipcyd = 4-iodophenylcyanamide anion, OHpcyd = 4-(3-hydroxy-3-methylbut-1-ynil)phenylcyanamide), have been prepared and characterized by UV-Vis, IR and ¹H NMR spectroscopies as well as electrochemical technique (CV). The complex cis-[Ru(bpy)₂(Ipcyd)₂] (1) crystallized with empirical formula of C₃₄H₂₄I₂N₈Ru in a monoclinic crystal system and space group of P2₁/c with a = 11.769(7) Å, b = 24.188(12) Å, c = 11.623(2) Å, β = 91.63(3)°, V = 3308(3) ų and Z = 4.     

A nearly symmetric trinuclear chromium(III) oxo carboxylate assembly: preparation, molecular and crystal structure, and magnetic properties of [Cr3O(O2CPh)6(MeOH)3](NO3) · 2MeOH

Complex [Cr₃O(O₂CPh)₆(MeOH)₃](NO₃) · 2MeOH (1 · 2MeOH) has been synthesized from the one-pot reaction between Cr(NO₃)₃ · 9H₂O and NaO₂CPh in MeOH. The structure of the complex has been solved by single-crystal X-ray crystallography. It crystallizes in the monoclinic space group P2₁/n with a=14.716(6) Å, b=22.569(8) Å, c=15.755(6) Å, β=95.02(1)°, V=5212.5(4) ų and Z=4. Although the cation does not possess any crystallographically imposed symmetry element, its {Cr₃(μ₃-O)} core is nearly symmetric. Each Cr^III…Cr^III vector is further bridged by two η¹:η¹:μ₂ benzoates, with a terminal MeOH molecule completing octahedral coordination at each metal ion. The crystal structure consists of layers that are parallel to (0 1 0) crystallographic plane and are formed through π-π stacking interactions and hydrogen bonds. Variable-temperature magnetic susceptibility and solid-state ¹H NMR studies indicate that the total spin value of the ground state is 1/2. EPR experiments reveal the existence of a distribution of trimers with axial anisotropy in the g tensor.     

Time-resolved small-angle X-ray scattering study of the folding dynamics of barnase

Structural changes of barnase during folding were investigated using time-resolved small-angle X-ray scattering (SAXS). The folding of barnase involves a burst-phase intermediate, sometimes designated as the denatured state under physiological conditions, D_phys, and a second hidden intermediate. Equilibrium SAXS measurements showed that the radius of gyration (R_g) of the guanidine unfolded state (U) is 26.9 ± 0.7 Å, which remains largely constant over a wide denaturant concentration range. Time-resolved SAXS measurements showed that the R_g value extrapolated from kinetic R_g data to time zero, R_g,0, is 24.3 ± 0.1 Å, which is smaller than that of U but which is expanded from that of folding intermediates of other proteins with similar chain lengths (19 Å). After the burst-phase change, a single-exponential reduction in R_g² was observed, which corresponds to the formation of the native state for the major component containing the native trans proline isomer. We estimated R_g of the minor component of D_phys containing the non-native cis proline isomer (D_phys,cis) to be 25.7 ± 0.6 Å. Moreover, R_g of the major component of D_phys containing the native proline isomer (D_phys,tra) was estimated as 23.9 ± 0.2 Å based on R_g,0. Consequently, both components of the burst-phase intermediate of barnase (D_phys,tra and D_phys,cis) are still largely expanded. It was inferred that D_phys possesses the N-terminal helix and the center of the β-sheet formed independently and that the formation of the remainder of the protein occurs in the slower phase.     

Novel triorganotin(IV) complexes of β-diketonates bearing two heterocycles in their structures

Novel triorganotin(IV) derivatives of β-diketonate Q ligands (HQ in general, in detail HQ^fur = 1-phenyl-3-methyl-4-(2-furancarbonyl)-pyrazol-5-one, HQ^thi = 1-phenyl-3-methyl-4-(2-thienylcarbonyl)-pyrazol-5-one) of general formula (Q)SnR₃·xH₂O (R = Ph, x = 0; R = Buⁿ or Me, x = 1) have been synthesized and spectroscopically and thermally characterized. Triphenyltin(IV) complexes have been isolated as anhydrous compounds while trialkyltin(IV) are always monohydrated. The structures of (Q^fur)SnPh₃ and (Q^thi)SnMe₃(OH₂) are recorded. The tin atoms are five-coordinate in both. In the first, the pyrazolonate ligand behaves as an O,O′-bidentate; there are two similar but independent molecules in the structure. In the quasi-trigonal-bipyramidal environments, Sn-O(acyl) are 2.478(3), 2.364(3), Sn-O(pyrazolonate) 2.050(2), 2.079(2), Sn-C 2.123(4)-2.162(3) Å with the longer O(acyl) and a phenyl group quasi-trans (O-Sn-C 162.5(1), 160.8(1)°). In (Q^thi)SnMe₃(OH₂), the three methyl groups are equatorial (Sn-C 2.1259(9)-2.1380(8) Å); Sn-O(Q^thi,OH₂) are 2.2143(5), 2.3350(6) Å, O-Sn-O 175.36(2)°. Trimethyltin(IV) derivatives decompose on heating with release of H₂O and SnMe₄ and formation of (Q)₂SnMe₂. Decomposition occurs also within two days after dissolution of (Q)SnMe₃(OH₂) in chloroform.     

Syntheses and properties of new metal-carbon bonded heteroleptic complexes of ruthenium(II) containing terpyridine coligand

Reactions of 2-(arylazo)aniline, HL [H represents the dissociable protons upon orthometallation and HL is p-RC₆H₄N = NC₆H₄-NH₂; R = H for HL¹; CH₃ for HL² and Cl for HL³] with Ru(R₁-tpy)Cl₃ (where R₁-tpy is 4′-(R₁)-2,2′,6′′,2′′-terpyridine and R₁ = H or 4-N,N-dimethylaminophenyl or 4-methylphenyl) afford a group of complexes of type [Ru(L)(R₁-tpy)]·ClO₄ each of which contains C,N,N coordinated L⁻ as a tridentate ligand along with a terpyridine. Structure of one such complex has been determined by X-ray crystallography. All the Ru(II) complexes are diamagnetic, display characteristic ¹H NMR signals and intense dπ(Ru^II) → π∗(tpy) MLCT transitions in the visible region. Cyclic voltammetric studies on [Ru(L)(R₁-tpy)]·ClO₄ complexes show Ru(II)-Ru(III) oxidation within 0.63-0.67 V versus SCE.     

Synthesis and crystal structure of the low-spin iron(II) complex [Fe(bpz)3](ClO4)2 · H2O (bpz=2,2-bipyrazine)

The crystal structure of the title compound [Fe(bpz)₃](ClO₄)₂ · H₂O (bpz=2,2^′-bipyrazine) has been determined by a single crystal X-ray diffraction study at 293(2) K. The complex is monoclinic, P2₁/c, a=17.263(3), b=9.983(2), c=17.921(4) Å, β=107.94(3)°, V=2938.3(10) ų, Z=4, R=0.073 and R_w=0.118. The structure is made up of tris-chelated [Fe(bpz)₃]²⁺ cations, uncoordinated perchlorate anions and crystallization water molecules. The iron atom exhibits a FeN₆ distorted octahedral geometry with average Fe-N bond length and N-Fe-N bidentate angle of 1.962(5) Å and 81.6(2)°. The value of the Fe-N bond distance and that of the room temperature magnetic moment are in agreement with a singlet ¹A₁ ground state. The structure of 1 is compared to those of other tris-chelated iron(II) complexes with bidentate nitrogen heterocycles.     

Praseodymium (III) complexes with 1,10-phenanthroline and cyanamide derivatives as N-donor ligands

The molecular structure of praseodymium (III) complex with 1,10-phenanthroline (phen), [Pr(phen)₂Cl₃·OH₂] (1) was determined by single-crystal X-ray diffraction. Crystal data: crystal system, triclinic, space group P and Z = 2, a = 7.1110(7) ?, b = 10.1716(10) ?, c = 17.2367(18) ?, α = 80.922(5)°, β = 78.759(5)°, γ = 70.151(5)°, R₁ = 0.036; wR₂ = 0.076 for all data. Treatment of aqueous solution of [Pr(phen)₂Cl₃·OH₂] (1) with thallium phenylcyanamide salts yield [Pr(phen)₂(L)₃] (L = pcyd (2), 2-Clpcyd (3), 2,3,5-Cl₃pcyd (4), 2,3,4,5-Cl₄pcyd (5)). Four new praseodymium (III) complexes have been characterized by IR, UV-Vis and ¹H NMR spectroscopy as well as elemental analysis. The ¹H NMR spectra of these complexes show broadening of ligand protons attributed to coordination of paramagnetic center.